Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing cells once transplanted into the body, the team successfully regulated blood sugar levels in diabetic mice.
An important step has been taken in Geneva against type 1 diabetes. An innovative hydrogel used on mice paves the way for a bioartifical pancreas to avoid insulin injection in the future, said the University of Geneva (UNIGE) on Monday.